Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ESPINEA is a Germany-based endoscopic spine training and education organization founded in 2019 by joimax. The organization focuses on scientific, evidence-based education for spine surgeons, with programs covering endoscopic and minimally invasive spinal surgery through workshops, fellowships, faculty programs, and related training activities. ESPINEA appears to operate as an academy and healthcare education initiative rather than a drug-development biotech or pharmaceutical company. Its activities are closely tied to surgeon training, procedural excellence, and dissemination of endoscopic spinal surgery techniques, including collaborations with joimax and external training partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ESPINEA Academy.